Comparative studies on activities of gentamicin, sisomicin, tobramycin and amikacin (BB-K8) against Pseudomonas sp.
D Dzierżanowska
Abstract
D Dzierżanowska
Abstract
Activities of gentamicin, sisomicin, tobramycin and amikacin against 561 strains of Pseudomonas sp. bacilli were evaluated. Tobramycin was from two to eight times more active against Pseudomonas sp. than gentamicin. No strains resistant to amikacin were encountered. Correlation between the size of the growth inhibition zone and minimal inhibitory concentration was determined as regression lines for all the tested antibiotics. Sisomicin and tobramycin showed lowest correlation, and gentamicin and amikacin good correlation.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Activities of gentamicin, sisomicin, tobramycin and amikacin against 561 strains of Pseudomonas sp. bacilli were evaluated. Tobramycin was from two to eight times more active against Pseudomonas sp. than gentamicin. No strains resistant to amikacin were encountered. Correlation between the size of the growth inhibition zone and minimal inhibitory concentration was determined as regression lines for all the tested antibiotics. Sisomicin and tobramycin showed lowest correlation, and gentamicin and amikacin good correlation.
Key concepts: Sisomicin, Tobramycin, Amikacin, Gentamicin, Microbiology, Pseudomonas, Aminoglycoside, Antibiotics